The EMA has launched a consultation on the circumstances in which single-arm trials (SATs) – those without a control group – can be used to support marketing applications for medicines…
Тhe Farmak delegation took part in the last conference and meeting of the ORBIS project in the city of Poznan, Poland. The project lasted 5 years as part of the…